Gastric antral vascular ectasia in systemic sclerosis: Where do we stand?

被引:8
作者
El-Gendy, Hala [1 ]
Shohdy, Kyrillus S. [1 ]
Maghraby, Gehad G. [1 ]
Abadeer, Kerolos [2 ]
Mahmoud, Moustafa [1 ]
机构
[1] Cairo Univ, Fac Med, Internal Med Dept, Rheumatol & Clin Immunol Unit, Al Saray St, Cairo 11451, Egypt
[2] Ain Shams Univ, Fac Med, Cairo, Egypt
关键词
argon therapy; cyclophosphamide; gastric antral vascular ectasia; systemic sclerosis; von Willebrand factor; VON-WILLEBRANDS-DISEASE; WATERMELON STOMACH; ANGIODYSPLASIA; THALIDOMIDE; MANAGEMENT; CLEARANCE; PATIENT; DEFECT;
D O I
10.1111/1756-185X.13047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gastric antral vascular ectasia (GAVE) continues to be a challenge in both diagnosis and treatment. GAVE has a diverse group of associations and presumed causes, including cirrhosis, chronic renal failure and autoimmune connective tissue diseases. However, in most occasions, the management plan of GAVE itself is the same whatever the underlying disease by using Argon plasma coagulation (APC). Herein, we will discuss three cases of systemic sclerosis-associated GAVE presenting with either acute or chronic gastrointestinal bleeding showing variable responses to APC. Anemia and telangiectasia may be the first striking presentation of systemic sclerosis (SSc). Renal artery stenosis, aortic stenosis, widespread cutaneous and mucosal telangiectasia and hypertension seem to be associated with poor prognosis and should prompt rapid intervention and careful follow-up. Moreover, the hunt for molecular underpinnings of the broad array of vascular lesions in SSc has to include von Willebrand factor and endoglin. Eventually, we will review the recent alternatives that can be effective in SSc-GAVE, such as band ligation, hematopoietic stem cells transplantation and immunotherapy.
引用
收藏
页码:2133 / 2139
页数:7
相关论文
共 34 条
[1]  
Alhumood SA, 1999, AM J HEMATOL, V60, P151, DOI 10.1002/(SICI)1096-8652(199902)60:2<151::AID-AJH13>3.0.CO
[2]  
2-J
[3]   The Clinical Picture A less common source of dyspnea in scleroderma [J].
Altahawi, Faysal ;
Alraies, M. Chadi .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2011, 78 (12) :801-802
[4]   Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis [J].
Barnes, Theresa ;
Gliddon, Angela ;
Dore, Caroline J. ;
Maddison, Peter ;
Moots, Robert J. .
RHEUMATOLOGY, 2012, 51 (09) :1606-1609
[5]   Autologous Hematopoietic Stem Cell Transplant for Systemic Sclerosis Improves Anemia from Gastric Antral Vascular Ectasia [J].
Bhattacharyya, Abir ;
Sahhar, Joanne ;
Milliken, Sam ;
Ma, David ;
Englert, Helen ;
Tymms, Kathleen ;
Danta, Mark ;
Moore, John .
JOURNAL OF RHEUMATOLOGY, 2015, 42 (03) :554-555
[6]  
Calamia KT, 2000, CLIN EXP RHEUMATOL, V18, P605
[7]  
Camargo C, 2014, SCAND J RHEUMATOL, V2014, P1
[8]  
FRESSINAUD E, 1994, THROMB HAEMOSTASIS, V71, P528
[9]   A clue for telangiectasis in systemic sclerosis: Elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease [J].
Fujimoto, M. ;
Hasegawa, M. ;
Hamaguchi, Y. ;
Komura, K. ;
Matsushita, T. ;
Yanaba, K. ;
Kodera, M. ;
Takehara, K. ;
Sato, S. .
DERMATOLOGY, 2006, 213 (02) :88-92
[10]   Efficacy of Thalidomide for Refractory Gastrointestinal Bleeding From Vascular Malformation [J].
Ge, Zhi-Zheng ;
Chen, Hui-Min ;
Gao, Yun-Jie ;
Liu, Wen-Zhong ;
Xu, Chun-Hong ;
Tan, Hong-Hong ;
Chen, Hai-Ying ;
Wei, Wei ;
Fang, Jing-Yuan ;
Xiao, Shu-Dong .
GASTROENTEROLOGY, 2011, 141 (05) :1629-U163